PubRank

O Boyer

Author PubWeight™ 21.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene. Transplantation 2000 1.43
2 A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther 1998 1.13
3 Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 2009 1.07
4 Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001 1.03
5 Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein. Am J Transplant 2012 1.01
6 Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene. Transgenic Res 1998 0.97
7 Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients. Clin Exp Immunol 2003 0.93
8 High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain. Methods Enzymol 2002 0.93
9 Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum Gene Ther 2000 0.92
10 Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes. J Immunol 1996 0.89
11 Would suicide gene therapy solve the 'T-cell dilemma' of allogeneic bone marrow transplantation? Immunol Today 1999 0.89
12 Immunological defects after suicide gene therapy of experimental graft-versus-host disease. Hum Gene Ther 1999 0.86
13 Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease. Mol Genet Metab 2013 0.85
14 T cell repertoire in patients with stable scleroderma. Clin Exp Immunol 2005 0.82
15 A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Study Group on Gene Therapy of Metastatic Melanoma. Hum Gene Ther 1998 0.81
16 Gene therapy for liver tumors. Surg Oncol Clin N Am 1996 0.81
17 Rapid screening of cryopreservation protocols for murine prepubertal testicular tissue by histology and PCNA immunostaining. J Androl 2010 0.80
18 Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 1997 0.79
19 Suicide gene-mediated modulation of graft-versus-host disease. Leuk Lymphoma 1999 0.79
20 Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study. Clin Exp Immunol 2015 0.79
21 Long-term survival after gene therapy for a recurrent glioblastoma. Neurology 2002 0.78
22 Deletional and mutational analyses of the human CD4 gene promoter: characterization of a minimal tissue-specific promoter. Biochim Biophys Acta 1998 0.77
23 Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease. Hum Gene Ther 2000 0.77
24 T-Cell suicide gene therapy for organ transplantation: induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression. Mol Ther 2000 0.77
25 Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells. Blood 2001 0.75
26 Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease. Gene Ther 2002 0.75
27 Extent of tumor-brain interface: a new tool to predict evolution of malignant gliomas. J Neurosurg 2001 0.75
28 [Statin-related inflammatory myopathy]. Rev Med Interne 2013 0.75
29 Lactate dehydrogenase isoenzyme LD5/LD2 ratio as an indicator of early graft function and complications following pediatric orthotopic liver transplantation. Transplant Proc 1995 0.75
30 Acquired factor VIII autoantibody (AAb) in the course of lipoid nephrosis. Nephrol Dial Transplant 1993 0.75